Skip to main content
    R

    Repare Therapeutics Inc (RPTX)

    Official site

    BIOTECHNOLOGY

    $2.65
    +0.00 (+0.00%)

    Last updated: Jan 28, 2026 at 4:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    57%(13/23)
    Avg Surprise
    -147.27%
    Streak
    2 Q
    PeriodReportedEst.SurpriseB/MYoY
    Sep 25
    Reported Nov 14
    		$0.08N/A+116.33%Beat+109.9%
    Jun 25
    Reported Aug 8
    		$-0.39$-0.56+30.36%Beat+52.4%
    Mar 25
    Reported May 13
    		$-0.71$-0.63-12.70%Miss-336.7%
    Dec 24
    Reported Mar 3
    		$-0.67$-0.81+17.28%Beat+0.0%
    Sep 24
    Reported Nov 7
    		$-0.81$-0.87+6.90%Beat-80.0%
    Jun 24
    Reported Aug 7
    		$-0.82$-0.87+5.75%Beat-192.9%
    Mar 24
    Reported May 7
    		$0.30N/A+138.30%Beat+136.1%
    Dec 23
    Reported Feb 28
    		$-0.67$-0.36-86.11%Miss+10.7%
    Sep 23
    Reported Nov 9
    		$-0.45$-0.86+47.67%Beat-126.3%
    Jun 23
    Reported Aug 9
    		$-0.28N/A+64.10%Beat+69.2%
    Mar 23
    Reported May 9
    		$-0.83$-0.81-2.47%Miss+0.0%
    Dec 22
    Reported Feb 28
    		$-0.75$-0.72-4.17%Miss-7.1%
    Sep 22
    Reported Nov 9
    		$1.71$-0.89+292.13%Beat+306.0%
    Jun 22
    Reported Aug 4
    		$-0.91$-0.85-7.06%Miss-28.2%
    Mar 22
    Reported May 5
    		$-0.83$-0.86+3.49%Beat-43.1%
    Dec 21
    Reported Mar 1
    		$-0.70$-0.74+5.41%Beat-70.7%
    Sep 21
    Reported Nov 10
    		$-0.83$-0.71-16.90%Miss-124.3%
    Jun 21
    Reported Aug 12
    		$-0.71$-0.60-18.33%Miss+71.0%
    Mar 21
    Reported May 13
    		$-0.58$-0.51-13.73%Miss+32.6%
    Dec 20
    Reported Mar 4
    		$-0.41$-0.39-5.13%Miss-
    Sep 20
    Reported Nov 11
    		$-0.37$-0.38+2.63%Beat-
    Jun 20
    Reported Aug 13
    		$-2.45$-0.06-3983.33%Miss-
    Mar 20
    Reported Jun 19
    		$-0.86$-1.27+32.28%Beat-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit MarginN/AOperating MarginN/A
    ROEN/AROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current RatioN/AQuick RatioN/A
    Trading Statistics
    BetaN/AAvg VolumeN/A
    52-Week HighN/A52-Week LowN/A

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$2.61
    SMA 20$2.59
    SMA 50$2.35
    SMA 200N/A
    EMA 10$2.61
    EMA 20$2.55
    EMA 50$2.36
    EMA 200$1.83

    MACD

    Line: 0.09Signal: 0.10Hist: -0.01

    ADX

    ADX: 41.8+DI: 31.5-DI: 14.4

    Aroon & PSAR

    Aroon Up12.0
    Aroon DownN/A
    PSAR$2.51

    Bollinger Bands

    Upper Band$2.65
    Lower Band$2.52
    %B Position489%(Upper)
    Band Width1.00

    RSI (14-Day)

    Overbought
    73.2

    Momentum Oscillators

    Stoch %K97.6
    Stoch %D93.1
    Williams %RN/A
    ROC (10d)2.5%
    Momentum0.07
    CCI (20d)187.0
    MFI (14d)43.0

    Volatility Measures

    ATR (14d)$0.05(1.9%)
    StdDev (20d)0.03
    Hist Vol11.2%(Low)

    Volume Flow

    VWAP$2.65
    OBV24.9M
    AD Line-21.2M
    CMF (20d)0.178

    Volume Metrics

    Avg Vol (20d)987.3K
    Vol RatioN/A
    VWMA (20d)$2.58

    Pivot Points

    R3$2.69
    R2$2.67
    R1$2.66
    Pivot Point$2.64
    S1$2.63
    S2$2.61
    S3$2.60

    Advanced Oscillators

    TSI40.86
    Ultimate Osc73.6
    KST133.37

    Financial Data

    QuarterSep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022
    Total Revenue$11.62M$250,000$0$-53,477,000$0$1.07M$52.40M$13.05M$2.16M$30.25M$5.68M$18.20M
    Cost of Revenue$0$0$0$454,000$0$0$0$506,000$0$0$0$27.55M
    Gross Profit$11.62M$250,000$0$-454,000$0$1.07M$52.40M$13.05M$2.16M$30.25M$5.68M$18.20M
    Operating Expenses$10.49M$18.03M$31.19M$30.65M$36.37M$38.39M$41.59M$43.91M$40.58M$42.51M$40.36M$37.83M
    R&D$7.50M$14.28M$20.27M$24.50M$28.40M$30.07M$32.97M$35.27M$32.71M$33.79M$31.83M$29.89M
    SG&A$4.55M$6.03M$7.65M$6.30M$6.44M$8.32M$8.62M$8.65M$7.87M$8.72M$8.53M$7.94M
    Operating Income$1.13M$-17,780,000$-31,187,000$-30,648,000$-36,372,000$-37,319,000$10.82M$-30,867,000$-38,418,000$-12,258,000$-34,681,000$-19,632,000
    Interest Income$2.22M$1.24M$1.54M$2.02M$2.51M$2.89M$2.97M$3.11M$3.31M$3.49M$3.43M$2.93M
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$3.40M$-16,496,000$-29,673,000$-28,671,000$-33,921,000$-34,448,000$13.79M$-27,840,000$-35,178,000$-8,836,000$-31,325,000$-16,630,000
    Income Tax Expense$145,000$248,000$370,000$0$485,000$326,000$629,000$190,000$-16,299,000$3.11M$3.62M$15.03M
    Net Income$3.26M$-16,744,000$-30,043,000$-28,671,000$-34,406,000$-34,774,000$13.16M$-28,030,000$-18,879,000$-11,946,000$-34,941,000$-31,658,000
    EBITDA$771,000$-17,169,000$-30,558,000$-31,093,000$-37,345,000$-38,517,000$10.08M$-32,096,000$-39,873,000$-13,908,000$-36,150,000$-20,606,000
    EBIT$1.18M$-17,732,000$-31,211,000$-30,688,000$-36,433,000$-37,342,000$10.82M$-30,946,000$-38,490,000$-12,325,000$-34,752,000$-19,561,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about RPTX

    News

    No news available

    Company news will appear here when available

    RPTX Competitors

    CompanyTicker
    OUTLOOK THERAPEUTICS INCOTLK
    Cumberland Pharmaceuticals IncCPIX
    Cassava Sciences IncSAVA
    Minerva Neurosciences IncNERV
    Seer IncSEER
    TuHURA Biosciences IncHURA
    Tenaya Therapeutics IncTNYA
    NRX Pharmaceuticals IncNRXP

    Sector: Healthcare

    RPTX Bull Case vs Bear Case

    Bull case

    • RPTX beat EPS estimates in 75.0% of its last 8 reported quarters.

    RPTX Earnings: Beat Rate and Next Report

    Beat rate
    6 of 8 quarters (75.0%)
    Average surprise
    27.0%

    Frequently Asked Questions About RPTX

    Does RPTX pay dividends?

    Repare Therapeutics Inc (RPTX) does not currently pay a regular dividend.

    Related stocks

    Sector: Healthcare

    All stocks starting with R

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In